<?xml version="1.0"?>
<rss version="2.0">
  <channel>
    <title>RxPG News : Letrozole</title>
      <link>http://www.rxpgnews.com/</link>
      <description>Medical News and Information</description>
      <pubDate>Thu, 21 Aug 2008 02:00:28 PST</pubDate>
      <language>en-us</language>
      <item>
        <title>Fertility drug letrozole given &#39;all-clear&#39; in new study</title>
        <link>http://www.rxpgnews.com/letrozole/Fertility_drug_letrozole_given_all-clear_in_new_st_4119_4119.shtml</link>
        <category>Letrozole</category>
        <description>Concerns about the use of letrozole, an easy-to-use and inexpensive drug for the treatment of infertility, appear to be unfounded, according to a major study coauthored by Dr. Togas Tulandi, Director of Division of Reproductive Endocrinology and Infertility, McGill University Health Centre (MUHC) and Chief of Obstetrics and Gynecology at the Jewish General Hospital, and Professor of Obstetrics and Gynecology at McGill University. Their findings, which are currently available in an early online edition of Fertility and Sterility, showed that babies whose mothers were treated with letrozole had the same rate of birth defects as those whose mothers were treated with clomiphene citrate  the low-risk, first-line treatment for infertility for more than 40 years.</description>
        <pubDate>Sat, 22 Apr 2006 18:57:00 PST</pubDate>
        <guid isPermaLink="true">http://www.rxpgnews.com/letrozole/Fertility_drug_letrozole_given_all-clear_in_new_st_4119_4119.shtml</guid>
      </item>


  </channel>
</rss>
